COM:BIODESIX
Biodesix
- Stock
Last Close
1.20
22/11 21:00
Market Cap
185.79M
Beta: -
Volume Today
702.98K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 700K - | ||||||
average payables | 1.30M - | 5.34M 310.33% | 5.31M 0.51% | 1.67M 68.50% | 2.31M 37.85% | ||
average receivables | 3.59M - | 10.30M 186.69% | 9.48M 7.94% | 4.36M 54.00% | 6.37M 46.13% | ||
book value per share | -7.58 - | -5.00 34.03% | 8.51 270.19% | 0.72 91.53% | 0.49 32.11% | 0.06 88.60% | |
capex per share | -0.02 - | -0.03 31.19% | -0.45 1,352.65% | -0.09 79.32% | -0.08 9.82% | -0.28 232.53% | |
capex to depreciation | -0.35 - | -0.51 42.97% | -0.75 47.92% | -0.80 6.87% | -0.60 24.55% | -4.16 588.22% | |
capex to operating cash flow | 0.03 - | 0.07 86.73% | 0.10 56.33% | 0.09 11.43% | 0.08 12.92% | 1.00 1,175.28% | |
capex to revenue | -0.03 - | -0.06 90.99% | -0.05 17.14% | -0.05 2.21% | -0.09 97.92% | -0.47 404.85% | |
cash per share | 0.23 - | 0.12 48.91% | 12.84 11,004.80% | 1.20 90.69% | 1.02 14.39% | 0.32 68.72% | |
days of inventory on hand | |||||||
days payables outstanding | 73.40 - | 103.18 40.57% | 148.73 44.15% | 19.88 86.64% | 43.45 118.60% | ||
days sales outstanding | 33.80 - | 78.67 132.77% | 122.61 55.85% | 24.48 80.03% | 48.38 97.61% | 57.10 18.02% | |
debt to assets | 0.59 - | 0.86 46.09% | 0.23 73.46% | 0.13 42.63% | 0.34 160.56% | 0.61 78.65% | |
debt to equity | -0.12 - | -0.16 34.94% | 0.67 528.53% | 0.51 24.75% | 1.55 204.55% | 13.25 757.32% | |
dividend yield | 0.00 - | ||||||
earnings yield | -0.08 - | -0.05 31.50% | -0.37 598.37% | -0.31 17.83% | -0.83 170.17% | -0.35 58.42% | |
enterprise value | 351.92M - | 616.26M 75.11% | 63.17M 89.75% | 122.06M 93.21% | 85.60M 29.87% | 185.49M 116.70% | |
enterprise value over ebitda | -20.07 - | -27.81 38.55% | -2.91 89.52% | -3.10 6.49% | -1.70 45.28% | -4.49 164.17% | |
ev to operating cash flow | -19.91 - | -28.36 42.48% | -2.96 89.58% | -4.32 46.27% | -1.90 55.99% | -8.11 326.13% | |
ev to sales | 17.22 - | 25.10 45.73% | 1.39 94.48% | 2.24 61.49% | 2.24 0.03% | 3.78 68.69% | |
free cash flow per share | -0.70 - | -0.51 27.69% | -4.87 861.23% | -1.12 76.89% | -1.15 2.46% | -0.56 51.60% | |
free cash flow yield | -0.05 - | -0.04 27.69% | -0.24 510.78% | -0.21 11.94% | -0.50 135.66% | -0.30 39.50% | |
graham net net | -8.79 - | -5.71 35.08% | -1.30 77.19% | -0.76 41.30% | -0.60 21.03% | -0.76 26.05% | |
graham number | 13.07 - | 8.78 32.78% | 37.99 332.50% | 5.13 86.48% | 4.59 10.70% | 0.89 80.53% | |
income quality | 0.68 - | 0.71 4.67% | 0.68 3.61% | 0.65 4.05% | 0.69 5.08% | 0.44 36.17% | |
intangibles to total assets | 0.71 - | 0.64 9.36% | 0.23 63.59% | 0.35 49.86% | 0.27 23.69% | 0.23 13.37% | |
interest coverage | -8.05 - | -7.52 6.50% | -2.91 61.34% | -8.72 199.88% | -6.26 28.26% | 4.34 169.29% | |
interest debt per share | 1.00 - | 0.85 14.35% | 7.31 757.37% | 0.53 92.74% | 0.95 78.70% | 0.62 34.30% | |
inventory turnover | |||||||
invested capital | -0.12 - | -0.16 34.94% | 0.67 528.53% | 0.51 24.75% | 1.55 204.55% | 13.25 757.32% | |
market cap | 334.74M - | 585.57M 74.93% | 97.53M 83.34% | 144.76M 48.42% | 96.84M 33.11% | 151.09M 56.02% | |
net current asset value | -227.17M - | -257.47M 13.34% | 6.24M 102.42% | -12.76M 304.57% | -18.97M 48.67% | -54.83M 189.11% | |
net debt to ebitda | -0.98 - | -1.38 41.28% | 1.59 214.47% | 0.58 63.59% | 0.22 61.37% | -0.83 473.23% | |
net income per share | -1.00 - | -0.69 31.50% | -7.54 999.08% | -1.63 78.44% | -1.91 17.47% | -0.64 66.74% | |
operating cash flow per share | -0.68 - | -0.48 29.74% | -4.42 829.20% | -1.03 76.65% | -1.07 3.57% | -0.28 73.92% | |
payables turnover | 4.97 - | 3.54 28.86% | 2.45 30.63% | 18.36 648.24% | 8.40 54.25% | ||
receivables turnover | 10.80 - | 4.64 57.04% | 2.98 35.84% | 14.91 400.83% | 7.54 49.40% | 6.39 15.27% | |
research and ddevelopement to revenue | 0.40 - | 0.43 6.39% | 0.24 44.31% | 0.23 1.19% | 0.34 46.13% | 0.20 40.66% | |
return on tangible assets | -2.30 - | -2.10 8.38% | -0.39 81.31% | -0.90 128.82% | -1.18 31.27% | -0.68 42.01% | |
revenue per share | 0.78 - | 0.54 31.31% | 9.42 1,653.20% | 1.99 78.85% | 0.91 54.43% | 0.60 34.13% | |
roe | 0.13 - | 0.14 3.83% | -0.89 745.78% | -2.25 154.49% | -3.90 73.02% | -11.39 191.85% | |
roic | 0.14 - | 0.12 11.31% | -0.37 411.30% | -1.36 265.04% | -1.05 23.16% | -0.46 56.46% | |
sales general and administrative to revenue | 1.27 - | 1.25 1.56% | |||||
shareholders equity per share | -7.58 - | -5.00 34.03% | 8.51 270.19% | 0.72 91.53% | 0.49 32.11% | 0.06 88.60% | |
stock based compensation to revenue | 0.01 - | 0.01 0.37% | 0.08 1,075.82% | 0.09 11.41% | 0.16 71.98% | 0.11 29.83% | |
tangible asset value | -225.69M - | -255.26M 13.10% | 12.88M 105.04% | -6.92M 153.76% | -4.22M 39.00% | -18.36M 334.91% | |
tangible book value per share | -8.64 - | -5.58 35.34% | 2.66 147.66% | -0.25 109.50% | -0.10 60.35% | -0.22 123.00% | |
working capital | 5.45M - | -9.90M 281.82% | 54.02M 645.61% | 14.65M 72.87% | 30.50M 108.11% | 6.27M 79.45% |
All numbers in (except ratios and percentages)